Intra-Cellular Therapies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ITCI and buy or sell other stocks, ETFs, and their options commission-free!

About ITCI

Intra-Cellular Therapies (ITI) develop new drugs for neuropsychiatric, neurologic diseases, and other Central Nervous System (CNS) disorders. The company integrates the work of medicinal scientists, pharmacologists, biologists, and clinical development scientists to create novel treatments. 

CEO
Sharon L. Mates, PhD
CEOSharon L. Mates, PhD
Employees
860
Employees860
Headquarters
Bedminster, New Jersey
HeadquartersBedminster, New Jersey
Founded
2002
Founded2002
Employees
860
Employees860

ITCI Key Statistics

Market cap
14.01B
Market cap14.01B
Price-Earnings ratio
-182.70
Price-Earnings ratio-182.70
Dividend yield
—
Dividend yield—
Average volume
1.90M
Average volume1.90M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$131.98
52 Week high$131.98
52 Week low
$64.09
52 Week low$64.09
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.